ARK Investment Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $47.9M | Sell |
36,273,288
-990,940
| -3% | -$1.77M | 0.37% | 52 |
|
|
2025
Q4 | $69.7M | Buy |
37,264,228
+6,340,125
| +21% | +$12.2M | 0.46% | 49 |
|
|
2025
Q3 | $39.6M | Sell |
30,924,103
-5,374,060
| -15% | -$7.28M | 0.24% | 62 |
|
|
2025
Q2 | $45M | Sell |
36,298,163
-180,278
| -0.5% | -$208K | 0.33% | 50 |
|
|
2025
Q1 | $43M | Buy |
36,478,441
+434,079
| +1% | +$666K | 0.43% | 43 |
|
|
2024
Q4 | $66M | Buy |
36,044,362
+2,637,961
| +8% | +$5.15M | 0.55% | 35 |
|
|
2024
Q3 | $56.8M | Buy |
33,406,401
+193,947
| +0.6% | +$319K | 0.52% | 36 |
|
|
2024
Q2 | $45.5M | Sell |
33,212,454
-77,683
| -0.2% | -$157K | 0.4% | 41 |
|
|
2024
Q1 | $125M | Sell |
33,290,137
-1,214,136
| -4% | -$7.11M | 0.86% | 31 |
|
|
2023
Q4 | $338M | Buy |
34,504,273
+4,681,833
| +16% | +$38.3M | 2% | 17 |
|
|
2023
Q3 | $249M | Buy |
29,822,440
+3,187,820
| +12% | +$36.4M | 1.91% | 18 |
|
|
2023
Q2 | $354M | Sell |
26,634,620
-1,119,059
| -4% | -$13.6M | 2.35% | 16 |
|
|
2023
Q1 | $321M | Buy |
27,753,679
+2,061,998
| +8% | +$20.5M | 2.21% | 17 |
|
|
2022
Q4 | $210M | Sell |
25,691,681
-3,000,813
| -10% | -$25.9M | 1.82% | 20 |
|
|
2022
Q3 | $167M | Buy |
28,692,494
+646,964
| +2% | +$3.71M | 1.16% | 23 |
|
|
2022
Q2 | $158M | Buy |
28,045,530
+786,009
| +3% | +$4.78M | 0.94% | 27 |
|
|
2022
Q1 | $248M | Buy |
27,259,521
+876,418
| +3% | +$10.1M | 1.04% | 26 |
|
|
2021
Q4 | $540M | Buy |
26,383,103
+3,660,028
| +16% | +$88.3M | 1.63% | 20 |
|
|
2021
Q3 | $581M | Buy |
22,723,075
+2,241,589
| +11% | +$66.4M | 1.39% | 22 |
|
|
2021
Q2 | $716M | Sell |
20,481,486
-819,705
| -4% | -$23.8M | 1.33% | 23 |
|
|
2021
Q1 | $710M | Sell |
21,301,191
-7,203,438
| -25% | -$252M | 1.41% | 17 |
|
|
2020
Q4 | $739M | Buy |
28,504,629
+8,659,849
| +44% | +$147M | 1.97% | 11 |
|
|
2020
Q3 | $196M | Buy |
19,844,780
+11,613,288
| +141% | +$66.9M | 1.16% | 28 |
|
|
2020
Q2 | $28.4M | Buy |
8,231,492
+4,038,433
| +96% | +$13.7M | 0.31% | 51 |
|
|
2020
Q1 | $12.8M | Buy |
4,193,059
+2,683,645
| +178% | +$11M | 0.32% | 51 |
|
|
2019
Q4 | $7.76M | Buy |
1,509,414
+752,617
| +99% | +$3.83M | 0.2% | 65 |
|
|
2019
Q3 | $3.9M | Buy |
+756,797
| New | +$4.23M | 0.09% | 82 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 211 |
|
|
2019
Q1 | – | Sell |
-590
| Closed | -$4K | – | 198 |
|
|
2018
Q4 | $4K | Sell |
590
-7,785,895
| -100% | -$49.3M | ﹤0.01% | 194 |
|
|
2018
Q3 | $42.1M | Buy |
7,786,485
+1,465,192
| +23% | +$6.29M | 1.27% | 30 |
|
|
2018
Q2 | $22.4M | Buy |
6,321,293
+2,036,596
| +48% | +$5.65M | 0.82% | 37 |
|
|
2018
Q1 | $8.78M | Buy |
4,284,697
+4,070,780
| +1,903% | +$10.6M | 0.44% | 53 |
|
|
2017
Q4 | $565K | Buy |
213,917
+179,192
| +516% | +$627K | 0.05% | 114 |
|
|
2017
Q3 | $182K | Buy |
+34,725
| New | +$149K | 0.02% | 121 |
|
Other funds holding PACB
VCM
NAMA